Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Austco Healthcare Limited ( (AU:AHC) ) has shared an update.
Austco Healthcare Limited announced a change in the director’s interest, with Clayton Astles acquiring 632,649 unlisted performance rights. This grant, approved by shareholders at the recent Annual General Meeting, reflects the company’s commitment to aligning executive incentives with long-term performance goals, potentially impacting stakeholder confidence and company operations positively.
The most recent analyst rating on (AU:AHC) stock is a Buy with a A$0.55 price target. To see the full list of analyst forecasts on Austco Healthcare Limited stock, see the AU:AHC Stock Forecast page.
More about Austco Healthcare Limited
Austco Healthcare Limited operates in the healthcare industry, focusing on providing advanced communication and clinical workflow solutions. The company is known for its innovative products and services that enhance patient care and improve operational efficiency in healthcare facilities.
Average Trading Volume: 246,245
Technical Sentiment Signal: Buy
Current Market Cap: A$153.6M
Learn more about AHC stock on TipRanks’ Stock Analysis page.